Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
19.28 EUR | +0.21% | +0.82% | -42.57% |
Dec. 03 | BAYER AG : JP Morgan reaffirms its Neutral rating | ZD |
Dec. 03 | ZBD Pharma Gets China Approval for Antibacterial Injection | MT |
Business description: Bayer AG
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Number of employees: 94,245
Sales by Activity: Bayer AG
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Crop Science | 19.85B | 18.85B | 20.22B | 25.18B | 23.29B |
Pharmaceuticals | 17.99B | 17.29B | 18.37B | 19.26B | 18.11B |
Consumer Health | 5.47B | 5.05B | 5.29B | 6.08B | 6.03B |
All Other | 2.65B | 372M | 203M | 219M | 239M |
Enabling Functions and Consolidation | -2.42B | -163M | -5M | -1M | -36M |
Geographical breakdown of sales: Bayer AG
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
United States | 13.56B | 12.88B | 13.4B | 15.68B | 14.59B |
Europe / Middle East / Africa (Excl. Germany & Switzerland) | 10.32B | 10.02B | 10.56B | 11.35B | 11.07B |
Brazil | 3.54B | 2.99B | 3.48B | 5.32B | 4.97B |
Asia / Pacific (Excl.China) | 4.88B | 4.78B | 4.99B | 5.19B | 4.74B |
Latin America (Excl. Brazil) | 3.12B | 2.91B | 3.16B | 3.97B | 3.96B |
China | 3.73B | 3.48B | 3.86B | 4.26B | 3.62B |
Germany | 2.36B | 2.36B | 2.54B | 2.48B | 2.45B |
North America (Excl.United States) | 1.53B | 1.47B | 1.56B | 1.89B | 1.67B |
Switzerland | 505M | 496M | 542M | 600M | 567M |
Managers: Bayer AG
Director | Title | Age | Since |
---|---|---|---|
William Anderson
CEO | Chief Executive Officer | 58 | 2023-05-31 |
Director of Finance/CFO | 55 | 2018-05-31 | |
Christian Rommel
CTO | Chief Tech/Sci/R&D Officer | 57 | 2021-01-31 |
Bijoy Sagar
CTO | Chief Tech/Sci/R&D Officer | 55 | 2020-05-31 |
Thomas Kornek
IRC | Investor Relations Contact | - | 2021-10-31 |
Members of the board: Bayer AG
Manager | Title | Age | Since |
---|---|---|---|
Paul Achleitner
BRD | Director/Board Member | 68 | 2002-03-31 |
André van Broich
BRD | Director/Board Member | 54 | 2012-03-31 |
Director/Board Member | 65 | 2022-03-31 | |
Frank Löllgen
BRD | Director/Board Member | 63 | 2015-10-31 |
Colleen Goggins
BRD | Director/Board Member | 69 | 2017-03-31 |
Heike Hausfeld
BRD | Director/Board Member | 59 | 2017-03-31 |
Chairman | 67 | 2020-04-27 | |
Ertharin Cousin
BRD | Director/Board Member | 67 | 2019-09-30 |
Director/Board Member | 67 | 2020-04-27 | |
Alberto Weisser
BRD | Director/Board Member | 68 | 2021-03-31 |
Holdings: Bayer AG
Name | Equities | % | Valuation |
---|---|---|---|
BAYER CROPSCIENCE LIMITED 71.43% | 32,102,999 | 71.43% | 2,531,206,542 $ |
CENTURY THERAPEUTICS, INC. 14.96% | 12,675,838 | 14.96% | 14,577,214 $ |
PYXIS ONCOLOGY, INC. 4.61% | 2,742,338 | 4.61% | 9,762,723 $ |
METAGENOMI, INC. 10.82% | 4,050,997 | 10.82% | 7,980,464 $ |
BOUNDLESS BIO, INC. 7.26% | 1,615,201 | 7.26% | 4,716,387 $ |
SENTI BIOSCIENCES, INC. 12.84% | 587,849 | 12.84% | 1,275,632 $ |
1,490,625 | 0.38% | 391,021 $ | |
AZITRA, INC. 0.63% | 48,324 | 0.63% | 24,065 $ |
Company details: Bayer AG
Group companies: Bayer AG
Name | Category and Sector |
---|---|
Bayer CropScience, Inc. (Philippines)
Bayer CropScience, Inc. (Philippines) Chemicals: AgriculturalProcess Industries Part of Bayer AG, Bayer CropScience, Inc. is a Filipino company that manufactures agricultural chemicals. The company is located in the Philippines. |
Chemicals: Agricultural
|
Bayer HealthCare Ltd.
| |
Bayer Corp.
Bayer Corp. Pharmaceuticals: MajorHealth Technology Bayer Corp. manufactures and markets pharmaceutical, healthcare, nutrition and materials products. The firm offers consumer care, diagnostics, diabetes and animal health products. It also provides material science products, which include coating, adhesive and sealant raw materials polycarbonates polyurethanes and thermoplastic polyurethane elastomers. The company was founded in 1973 and is based in Whippany, NJ. |
Pharmaceuticals: Major
|
Bayer Healthcare LLC
Bayer Healthcare LLC Pharmaceuticals: MajorHealth Technology Bayer Healthcare LLC provides healthcare and pharmaceutical medicines. It also provides researching, developing, manufacturing and marketing services for the prevention, diagnosis and treatment of diseases. The company is headquartered in Whippany, NJ. |
Pharmaceuticals: Major
|
Bayer, Inc.
Bayer, Inc. Chemicals: AgriculturalProcess Industries Bayer, Inc. manufactures chemicals, healthcare, agricultural, and life science products. The company develops products that fight diseases, protects crops and animals, as well as develops materials. It was founded in 1936 and is headquartered in Toronto, Canada |
Chemicals: Agricultural
|
Other Pharmaceuticals
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
+0.01% | +0.38% | -37.62% | -56.87% | 19.86B | ||
+1.69% | +3.04% | +39.26% | +231.19% | 732B | ||
-0.45% | +4.80% | +12.55% | +119.90% | 488B | ||
-1.58% | -1.40% | -3.80% | -4.40% | 367B | ||
-0.15% | +0.20% | +26.56% | +52.71% | 321B | ||
+1.23% | +0.23% | -1.56% | +38.87% | 258B | ||
-0.12% | +0.55% | +3.09% | -30.92% | 231B | ||
-1.89% | -1.61% | +5.94% | +22.28% | 210B | ||
-2.64% | -0.19% | +2.40% | +25.70% | 212B | ||
+0.08% | -0.60% | +2.15% | +37.48% | 150B | ||
Average | -0.38% | +0.68% | +4.90% | +43.59% | 298.69B | |
Weighted average by Cap. | -0.31% | +1.24% | +14.61% | +87.23% |
Sector
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BAYN Stock
- Company Bayer AG